Literature DB >> 15279591

Cytopenias in HIV infection: mechanisms and alleviation of hematopoietic inhibition.

Prasad S Koka1, Srinivasa T Reddy.   

Abstract

Hematopoietic abnormalities including anemia, cytopenias, and alterations of the stem cell plasticity in the bone marrow microenvironment commonly occur in HIV infected patients. These observations suggest that HIV-1 infection may affect processes important during early stages of hematopoiesis or stem cell differentiation. Hematopoietic abnormalities may be caused by altered stem cell differentiation possibly due to abnormal lineage specific expression of certain cellular genes such as cytokines relevant to hematopoiesis. These cytokines could affect regulatory signals important in hematopoiesis. However, in HIV infected individuals, it is not only the virus but also the highly active antiretroviral therapy (HAART) that both contribute to persistent hematopoietic suppression and ensuing cytopenias. Even if a lowering of HIV replication by HAART were to occur in infected individuals, prolonged HAART by itself and/or appearance of drug resistant mutants can contribute to hematopoietic suppression and resulting cytopenias. However, confounding factors such as opportunistic infections, immune mediated effects, or the consequences of prolonged physiological stress, which could contribute to decreased hematopoiesis in patients or other individuals, make the causative role of HIV in vivo, uncertain. The severe combined immunodeficient mouse transplanted with human fetal thymus and liver tissues (SCID-hu) is a small animal model which mimics HIV infection in humans, and is useful to determine the mechanisms of HIV-1 induced hematopoietic inhibition and development of drug therapies for interventions of stem cell differentiation. Further, SCID mouse serves as a useful small animal recipient of human progenitor cells and also allows us to study the differentiation of these cells in vivo. Results from our studies are expected to provide relief for HIV infected individuals from hematopoietic inhibition and ensuing cytopenias. Copyright 2004 Bentham Science Publishers Ltd.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15279591     DOI: 10.2174/1570162043351282

Source DB:  PubMed          Journal:  Curr HIV Res        ISSN: 1570-162X            Impact factor:   1.581


  21 in total

1.  HIV-1 determinants of thrombocytopenia at the stage of CD34+ progenitor cell differentiation in vivo lie in the viral envelope gp120 V3 loop region.

Authors:  Menghua Zhang; Stella Evans; Jinyun Yuan; Lee Ratner; Prasad S Koka
Journal:  Virology       Date:  2010-03-24       Impact factor: 3.616

2.  Erythropoiesis in HIV-infected and uninfected Malawian children with severe anemia.

Authors:  Job C J Calis; Kamija S Phiri; Raymond J W M Vet; Rob J de Haan; Francis Munthali; Robert J Kraaijenhagen; Paul J M Hulshof; Malcolm E Molyneux; Bernard J Brabin; Michaël Boele van Hensbroek; Imelda Bates
Journal:  AIDS       Date:  2010-11-27       Impact factor: 4.177

3.  Stem Cells in Aging: Influence of Ontogenic, Genetic and Environmental Factors.

Authors:  Edmond J Yunis; Joaquin Zúñiga; Prasad S Koka; Zaheed Husain; Viviana Romero; Joel N H Stern; Masha Fridkis-Hareli
Journal:  J Stem Cells       Date:  2006

4.  A polymorphism in the leptin gene promoter is associated with anemia in patients with HIV disease.

Authors:  Gary J Vanasse; Jee-Yeong Jeong; Janet Tate; Harini Bathulapalli; Damon Anderson; Hanno Steen; Mark Fleming; Kristin Mattocks; Amalio Telenti; Jacques Fellay; Amy C Justice; Nancy Berliner
Journal:  Blood       Date:  2011-09-16       Impact factor: 22.113

5.  Effects of simian betaretrovirus serotype 1 (SRV1) infection on the differentiation of hematopoietic progenitor cells (CD34+) derived from bone marrow of rhesus macaques (Macaca mulatta).

Authors:  Nestor A Montiel; Patricia A Todd; JoAnn Yee; Nicholas W Lerche
Journal:  Comp Med       Date:  2012-02       Impact factor: 0.982

6.  Targeting c-Mpl for revival of human immunodeficiency virus type 1-induced hematopoietic inhibition when CD34+ progenitor cells are re-engrafted into a fresh stromal microenvironment in vivo.

Authors:  Prasad S Koka; Christina M R Kitchen; Srinivasa T Reddy
Journal:  J Virol       Date:  2004-10       Impact factor: 5.103

7.  Loss of bone marrow NK cells during SIV infection is associated with increased turnover rates and cytotoxicity but not changes in trafficking.

Authors:  Haiying Li; Tristan I Evans; R Keith Reeves
Journal:  J Med Primatol       Date:  2013-07-30       Impact factor: 0.667

8.  Human and simian immunodeficiency viruses deregulate early hematopoiesis through a Nef/PPARgamma/STAT5 signaling pathway in macaques.

Authors:  Stéphane Prost; Mikael Le Dantec; Sylvie Augé; Roger Le Grand; Sonia Derdouch; Gwenaelle Auregan; Nicole Déglon; Francis Relouzat; Anne-Marie Aubertin; Bernard Maillere; Isabelle Dusanter-Fourt; Marek Kirszenbaum
Journal:  J Clin Invest       Date:  2008-05       Impact factor: 14.808

9.  Chimeric SCID-hu Model as a Human Hematopoietic Stem Cell Host That Recapitulates the Effects of HIV-1 on Bone Marrow Progenitors in Infected Patients.

Authors:  I Birgitta Sundell; Prasad S Koka
Journal:  J Stem Cells       Date:  2006

10.  Natural Killer Cell Receptor NKG2A/HLA-E Interaction Dependent Differential Thymopoiesis of Hematopoietic Progenitor Cells Influences the Outcome of HIV Infection.

Authors:  Edmond J Yunis; Viviana Romero; Felipe Diaz-Giffero; Joaquin Zuñiga; Prasad Koka
Journal:  J Stem Cells       Date:  2007
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.